Orion Biotech Opportunities Corp. functions as a blank check company, meaning its primary goal is to undertake a business combination – such as a merger, acquisition of assets or shares, or a corporate reorganization – with one or more existing businesses. Established in 2021, the company is headquartered in New York, New York.
